TITLE: :@0.100053:0.272513:0.184107:0.272513:0.184107:0.255896:0.100053:0.255896:0.015686:0.009054:0.015686:0.015686:0.015686:0.006373:0.005881
PARADIGM SHIFT IN ANTIDOPING ANALYSIS:@0.184119:0.272513:0.734604:0.272513:0.734604:0.255896:0.184119:0.255896:0.014205:0.018132:0.018132:0.018132:0.019355:0.009054:0.019355:0.023283:0.005879:0.012982:0.019355:0.009054:0.015686:0.015686:0.005879:0.009054:0.019355:0.005879:0.018132:0.019355:0.015686:0.009054:0.019355:0.018132:0.014205:0.009054:0.019355:0.019355:0.005879:0.018132:0.019355:0.018132:0.015686:0.018132:0.012982:0.009054:0.012984
Date::@0.100053:0.295665:0.154451:0.295665:0.154451:0.279049:0.100053:0.279049:0.018132:0.011759:0.007831:0.010301:0.006375
 29th September 2023:@0.154455:0.295665:0.369552:0.295665:0.369552:0.279049:0.154455:0.279049:0.005879:0.011759:0.011759:0.007831:0.012982:0.005879:0.012982:0.010301:0.012982:0.007831:0.010301:0.019355:0.012982:0.010301:0.009054:0.005879:0.011759:0.011759:0.011759:0.011761
Details of participants::@0.100053:0.318817:0.323215:0.318817:0.323215:0.302201:0.100053:0.302201:0.018132:0.010301:0.007831:0.011759:0.006373:0.006373:0.009054:0.005879:0.011759:0.007831:0.005879:0.011759:0.011759:0.009054:0.007831:0.006373:0.010301:0.006373:0.011759:0.011759:0.011759:0.007831:0.009054:0.006375
 MSc. Forensic Science students.:@0.323217:0.318817:0.649340:0.318817:0.649340:0.302201:0.323217:0.302201:0.005879:0.023283:0.012982:0.010301:0.006373:0.005879:0.015686:0.012982:0.009054:0.010301:0.012982:0.009054:0.006373:0.010301:0.005879:0.012982:0.010301:0.006373:0.010301:0.012982:0.010301:0.010301:0.005879:0.009054:0.007831:0.012982:0.012982:0.010301:0.012982:0.007831:0.009054:0.006375
Resource Persons: :@0.100053:0.365122:0.284307:0.365122:0.284307:0.348505:0.100053:0.348505:0.016909:0.010301:0.009054:0.011759:0.011759:0.009054:0.010301:0.010301:0.005879:0.015686:0.010301:0.009054:0.009054:0.011759:0.011759:0.009054:0.006387:0.005881
Dr. Shobha Ahi, Deputy Director, Drug Control Centre, Department of:@0.100053:0.388274:0.823699:0.388274:0.823699:0.371658:0.100053:0.371658:0.019355:0.009054:0.006373:0.005879:0.012982:0.012982:0.012982:0.012982:0.012982:0.011759:0.005879:0.018132:0.012982:0.006373:0.006373:0.005879:0.019355:0.010301:0.012982:0.012982:0.007831:0.011759:0.005879:0.019355:0.006373:0.009054:0.010301:0.010301:0.007831:0.012982:0.009054:0.006373:0.005879:0.019355:0.009054:0.012982:0.011759:0.005879:0.016909:0.012982:0.012982:0.007831:0.009054:0.012982:0.006373:0.005879:0.016909:0.010301:0.012982:0.007831:0.009054:0.010301:0.006373:0.005879:0.019355:0.010301:0.012982:0.011759:0.009054:0.007831:0.019355:0.010301:0.012982:0.007831:0.005879:0.012982:0.007833
Analytical, Environmental and Forensic Sciences School of Cancer and:@0.100053:0.411426:0.813023:0.411426:0.813023:0.394810:0.100053:0.394810:0.018132:0.012982:0.011759:0.006373:0.011759:0.007831:0.006373:0.010301:0.011759:0.006373:0.006373:0.005879:0.015686:0.012982:0.011759:0.006373:0.009054:0.012982:0.012982:0.019355:0.010301:0.012982:0.007831:0.011759:0.006373:0.005879:0.011759:0.012982:0.012982:0.005879:0.015686:0.012982:0.009054:0.010301:0.012982:0.009054:0.006373:0.010301:0.005879:0.012982:0.010301:0.006373:0.010301:0.012982:0.010301:0.010301:0.009054:0.005879:0.012982:0.010301:0.012982:0.012982:0.012982:0.006373:0.005879:0.012982:0.007831:0.005879:0.016909:0.011759:0.012982:0.010301:0.010301:0.009054:0.005879:0.011759:0.012982:0.012984
Pharmaceutical Sciences, King's College, London:@0.100053:0.434578:0.593531:0.434578:0.593531:0.417962:0.100053:0.417962:0.014205:0.012982:0.011759:0.009054:0.019355:0.011759:0.010301:0.010301:0.012982:0.007831:0.006373:0.010301:0.011759:0.006373:0.005879:0.012982:0.010301:0.006373:0.010301:0.012982:0.010301:0.010301:0.009054:0.006373:0.005879:0.019355:0.006373:0.012982:0.011759:0.004163:0.009054:0.005880:0.016909:0.012982:0.006373:0.006373:0.010301:0.011759:0.010301:0.006373:0.005879:0.015686:0.012982:0.012982:0.012982:0.012982:0.012984
Brief Summary of Expert Guest lecture:@0.100053:0.480883:0.483702:0.480883:0.483702:0.464267:0.100053:0.464267:0.015686:0.009054:0.006373:0.010301:0.007831:0.005879:0.014205:0.011759:0.018132:0.018132:0.011759:0.009054:0.011759:0.005879:0.011759:0.007831:0.005879:0.015686:0.012982:0.011759:0.010301:0.009054:0.007831:0.005879:0.018132:0.011759:0.010301:0.009054:0.007831:0.005879:0.006373:0.010301:0.010301:0.007831:0.011759:0.009054:0.010303
On September 29, 2023, an enlightening international guest lecture was hosted:@0.100053:0.527188:0.879603:0.527188:0.879603:0.510571:0.100053:0.510571:0.018132:0.012982:0.005879:0.012982:0.010301:0.012982:0.007831:0.010301:0.019355:0.012982:0.010301:0.009054:0.005879:0.011759:0.011759:0.006373:0.005879:0.011759:0.011759:0.011759:0.011759:0.006373:0.005879:0.011759:0.012982:0.005879:0.010301:0.012982:0.006373:0.006373:0.011759:0.012982:0.007831:0.010301:0.012982:0.006373:0.012982:0.011759:0.005879:0.006373:0.012982:0.007831:0.010301:0.009054:0.012982:0.011759:0.007831:0.006373:0.012982:0.012982:0.011759:0.006373:0.005879:0.011759:0.012982:0.010301:0.009054:0.007831:0.005879:0.006373:0.010301:0.010301:0.007831:0.012982:0.009054:0.010301:0.005879:0.016909:0.011759:0.009054:0.005879:0.012982:0.012982:0.009054:0.007831:0.010301:0.012984
via Zoom, focusing on the topic \Paradigm Shift in Antidoping Analysis.\ The:@0.100053:0.550340:0.883717:0.550340:0.883717:0.533724:0.100053:0.533724:0.011759:0.006373:0.011759:0.005879:0.015686:0.012982:0.012982:0.019355:0.006373:0.005879:0.007831:0.012982:0.010301:0.012982:0.009054:0.006373:0.012982:0.011759:0.005879:0.012982:0.012982:0.005879:0.007831:0.012982:0.010301:0.005879:0.007831:0.012982:0.012982:0.006373:0.010301:0.005879:0.009548:0.014205:0.011759:0.009054:0.011759:0.012982:0.006373:0.011759:0.019355:0.005879:0.012982:0.012982:0.006373:0.007831:0.007831:0.005879:0.006373:0.012982:0.005879:0.018132:0.012982:0.007831:0.006373:0.012982:0.012982:0.012982:0.006373:0.012982:0.011759:0.005879:0.018132:0.012982:0.011759:0.006373:0.011759:0.009054:0.006373:0.009054:0.006373:0.009548:0.005879:0.015686:0.012982:0.010303
distinguished speaker for this event was Dr. Shobha Ahi, the Deputy Director:@0.100053:0.573492:0.877085:0.573492:0.877085:0.556876:0.100053:0.556876:0.012982:0.006373:0.009054:0.007831:0.006373:0.012982:0.011759:0.012982:0.006373:0.009054:0.012982:0.010301:0.012982:0.005879:0.009054:0.012982:0.010301:0.011759:0.012982:0.010301:0.009054:0.005879:0.007831:0.012982:0.009054:0.005879:0.007831:0.012982:0.006373:0.009054:0.005879:0.010301:0.011759:0.010301:0.012982:0.007831:0.005879:0.016909:0.011759:0.009054:0.005879:0.019355:0.009054:0.006373:0.005879:0.012982:0.012982:0.012982:0.012982:0.012982:0.011759:0.005879:0.018132:0.012982:0.006373:0.006373:0.005879:0.007831:0.012982:0.010301:0.005879:0.019355:0.010301:0.012982:0.012982:0.007831:0.011759:0.005879:0.019355:0.006373:0.009054:0.010301:0.010301:0.007831:0.012982:0.009056
of the Drug Control Centre, King's College, London. Dr. Shobha Ahi's lecture:@0.100053:0.596644:0.884000:0.596644:0.884000:0.580028:0.100053:0.580028:0.012982:0.007831:0.005879:0.007831:0.012982:0.010301:0.005879:0.019355:0.009054:0.012982:0.011759:0.005879:0.016909:0.012982:0.012982:0.007831:0.009054:0.012982:0.006373:0.005879:0.016909:0.010301:0.012982:0.007831:0.009054:0.010301:0.006373:0.005879:0.019355:0.006373:0.012982:0.011759:0.004163:0.009054:0.005879:0.016909:0.012982:0.006373:0.006373:0.010301:0.011759:0.010301:0.006373:0.005879:0.015686:0.012982:0.012982:0.012982:0.012982:0.012982:0.006373:0.005879:0.019355:0.009054:0.006373:0.005879:0.012982:0.012982:0.012982:0.012982:0.012982:0.011759:0.005879:0.018132:0.012982:0.006373:0.004163:0.009054:0.005879:0.006373:0.010301:0.010301:0.007831:0.012982:0.009054:0.010303
covered various aspects of the paradigm shift occurring in antidoping analysis,:@0.100053:0.619797:0.883435:0.619797:0.883435:0.603180:0.100053:0.603180:0.010301:0.012982:0.011759:0.010301:0.009054:0.010301:0.012982:0.005879:0.011759:0.011759:0.009054:0.006373:0.012982:0.012982:0.009054:0.005879:0.011759:0.009054:0.012982:0.010301:0.010301:0.007831:0.009054:0.005879:0.012982:0.007831:0.005879:0.007831:0.012982:0.010301:0.005879:0.012982:0.011759:0.009054:0.011759:0.012982:0.006373:0.011759:0.019355:0.005879:0.009054:0.012982:0.006373:0.007831:0.007831:0.005879:0.012982:0.010301:0.010301:0.012982:0.009054:0.009054:0.006373:0.012982:0.011759:0.005879:0.006373:0.012982:0.005879:0.011759:0.012982:0.007831:0.006373:0.012982:0.012982:0.012982:0.006373:0.012982:0.011759:0.005879:0.011759:0.012982:0.011759:0.006373:0.011759:0.009054:0.006373:0.009054:0.006375
focusing on advancements in technology, legal implications, and the impact on:@0.100053:0.642949:0.885505:0.642949:0.885505:0.626333:0.100053:0.626333:0.007831:0.012982:0.010301:0.012982:0.009054:0.006373:0.012982:0.011759:0.005879:0.012982:0.012982:0.005879:0.011759:0.012982:0.011759:0.011759:0.012982:0.010301:0.010301:0.019355:0.010301:0.012982:0.007831:0.009054:0.005879:0.006373:0.012982:0.005879:0.007831:0.010301:0.010301:0.012982:0.012982:0.012982:0.006373:0.012982:0.011759:0.011759:0.006373:0.005879:0.006373:0.010301:0.011759:0.011759:0.006373:0.005879:0.006373:0.019355:0.012982:0.006373:0.006373:0.010301:0.011759:0.007831:0.006373:0.012982:0.012982:0.009054:0.006373:0.005879:0.011759:0.012982:0.012982:0.005879:0.007831:0.012982:0.010301:0.005879:0.006373:0.019355:0.012982:0.011759:0.010301:0.007831:0.005879:0.012982:0.012984
sporting communities worldwide. Some key highlights of the lecture includes:@0.100053:0.666101:0.864668:0.666101:0.864668:0.649485:0.100053:0.649485:0.009054:0.012982:0.012982:0.009054:0.007831:0.006373:0.012982:0.011759:0.005879:0.010301:0.012982:0.019355:0.019355:0.012982:0.012982:0.006373:0.007831:0.006373:0.010301:0.009054:0.005879:0.016909:0.012982:0.009054:0.006373:0.012982:0.016909:0.006373:0.012982:0.010301:0.006373:0.005879:0.012982:0.012982:0.019355:0.010301:0.005879:0.012982:0.010301:0.011759:0.005879:0.012982:0.006373:0.011759:0.012982:0.006373:0.006373:0.011759:0.012982:0.007831:0.009054:0.005879:0.012982:0.007831:0.005879:0.007831:0.012982:0.010301:0.005879:0.006373:0.010301:0.010301:0.007831:0.012982:0.009054:0.010301:0.005879:0.006373:0.012982:0.010301:0.006373:0.012982:0.012982:0.010301:0.009056
Technological Advancements in Antidoping Analysis and Biological Passports:@0.100053:0.689253:0.884987:0.689253:0.884987:0.672637:0.100053:0.672637:0.015686:0.010301:0.010301:0.012982:0.012982:0.012982:0.006373:0.012982:0.011759:0.006373:0.010301:0.011759:0.006373:0.005879:0.018132:0.012982:0.011759:0.011759:0.012982:0.010301:0.010301:0.019355:0.010301:0.012982:0.007831:0.009054:0.005879:0.006373:0.012982:0.005879:0.018132:0.012982:0.007831:0.006373:0.012982:0.012982:0.012982:0.006373:0.012982:0.011759:0.005879:0.018132:0.012982:0.011759:0.006373:0.011759:0.009054:0.006373:0.009054:0.005879:0.011759:0.012982:0.012982:0.005879:0.015686:0.006373:0.012982:0.006373:0.012982:0.011759:0.006373:0.010301:0.011759:0.006373:0.005879:0.014205:0.011759:0.009054:0.009054:0.012982:0.012982:0.009054:0.007831:0.009056
and Athlete Biological Passport (ABP). The lecture delved into the concept of:@0.100053:0.712406:0.874733:0.712406:0.874733:0.695790:0.100053:0.695790:0.011759:0.012982:0.012982:0.005879:0.018132:0.007831:0.012982:0.006373:0.010301:0.007831:0.010301:0.005879:0.015686:0.006373:0.012982:0.006373:0.012982:0.011759:0.006373:0.010301:0.011759:0.006373:0.005879:0.014205:0.011759:0.009054:0.009054:0.012982:0.012982:0.009054:0.007831:0.005880:0.007831:0.018132:0.015686:0.014205:0.007831:0.006373:0.005879:0.015686:0.012982:0.010301:0.005879:0.006373:0.010301:0.010301:0.007831:0.012982:0.009054:0.010301:0.005879:0.012982:0.010301:0.006373:0.011759:0.010301:0.012982:0.005879:0.006373:0.012982:0.007831:0.012982:0.005879:0.007831:0.012982:0.010301:0.005879:0.010301:0.012982:0.012982:0.010301:0.010301:0.012982:0.007831:0.005879:0.012982:0.007833
biological passports and the ABP, outlining how these innovative tools are:@0.100053:0.735558:0.844513:0.735558:0.844513:0.718942:0.100053:0.718942:0.012982:0.006373:0.012982:0.006373:0.012982:0.011759:0.006373:0.010301:0.011759:0.006373:0.005879:0.012982:0.011759:0.009054:0.009054:0.012982:0.012982:0.009054:0.007831:0.009054:0.005879:0.011759:0.012982:0.012982:0.005879:0.007831:0.012982:0.010301:0.005879:0.018132:0.015686:0.014205:0.006373:0.005879:0.012982:0.012982:0.007831:0.006373:0.006373:0.012982:0.006373:0.012982:0.011759:0.005879:0.012982:0.012982:0.016909:0.005879:0.007831:0.012982:0.010301:0.009054:0.010301:0.005879:0.006373:0.012982:0.012982:0.012982:0.011759:0.011759:0.007831:0.006373:0.011759:0.010301:0.005879:0.007831:0.012982:0.012982:0.006373:0.009054:0.005879:0.011759:0.009054:0.010303
transforming antidoping strategies. Dr. Ahi emphasized their role in providing:@0.100053:0.758710:0.883200:0.758710:0.883200:0.742094:0.100053:0.742094:0.007831:0.009054:0.011759:0.012982:0.009054:0.007831:0.012982:0.009054:0.019355:0.006373:0.012982:0.011759:0.005879:0.011759:0.012982:0.007831:0.006373:0.012982:0.012982:0.012982:0.006373:0.012982:0.011759:0.005879:0.009054:0.007831:0.009054:0.011759:0.007831:0.010301:0.011759:0.006373:0.010301:0.009054:0.006373:0.005879:0.019355:0.009054:0.006373:0.005879:0.018132:0.012982:0.006373:0.005879:0.010301:0.019355:0.012982:0.012982:0.011759:0.009054:0.006373:0.010301:0.010301:0.012982:0.005879:0.007831:0.012982:0.010301:0.006373:0.009054:0.005879:0.009054:0.012982:0.006373:0.010301:0.005879:0.006373:0.012982:0.005879:0.012982:0.009054:0.012982:0.011759:0.006373:0.012982:0.006373:0.012982:0.011761
a longitudinal profile of an athlete's biological markers, enhancing the detection:@0.100053:0.781863:0.896018:0.781863:0.896018:0.765246:0.100053:0.765246:0.011759:0.005879:0.006373:0.012982:0.012982:0.011759:0.006373:0.007831:0.012982:0.012982:0.006373:0.012982:0.011759:0.006373:0.005879:0.012982:0.009054:0.012982:0.007831:0.006373:0.006373:0.010301:0.005879:0.012982:0.007831:0.005879:0.011759:0.012982:0.005879:0.011759:0.007831:0.012982:0.006373:0.010301:0.007831:0.010301:0.004163:0.009054:0.005879:0.012982:0.006373:0.012982:0.006373:0.012982:0.011759:0.006373:0.010301:0.011759:0.006373:0.005879:0.019355:0.011759:0.009054:0.012982:0.010301:0.009054:0.009054:0.006373:0.005879:0.010301:0.012982:0.012982:0.011759:0.012982:0.010301:0.006373:0.012982:0.011759:0.005879:0.007831:0.012982:0.010301:0.005879:0.012982:0.010301:0.007831:0.010301:0.010301:0.007831:0.006373:0.012982:0.012984
of doping practices over time. The lecture concluded with a discussion on the:@0.100053:0.805015:0.867137:0.805015:0.867137:0.788399:0.100053:0.788399:0.012982:0.007831:0.005879:0.012982:0.012982:0.012982:0.006373:0.012982:0.011759:0.005879:0.012982:0.009054:0.011759:0.010301:0.007831:0.006373:0.010301:0.010301:0.009054:0.005879:0.012982:0.011759:0.010301:0.009054:0.005879:0.007831:0.006373:0.019355:0.010301:0.006373:0.005879:0.015686:0.012982:0.010301:0.005879:0.006373:0.010301:0.010301:0.007831:0.012982:0.009054:0.010301:0.005879:0.010301:0.012982:0.012982:0.010301:0.006373:0.012982:0.012982:0.010301:0.012982:0.005879:0.016909:0.006373:0.007831:0.012982:0.005879:0.011759:0.005879:0.012982:0.006373:0.009054:0.010301:0.012982:0.009054:0.009054:0.006373:0.012982:0.012982:0.005879:0.012982:0.012982:0.005879:0.007831:0.012982:0.010303
future directions of antidoping analysis using dried blood spots (DBS),:@0.100053:0.828167:0.806225:0.828167:0.806225:0.811551:0.100053:0.811551:0.007831:0.012982:0.007831:0.012982:0.009054:0.010301:0.005879:0.012982:0.006373:0.009054:0.010301:0.010301:0.007831:0.006373:0.012982:0.012982:0.009054:0.005879:0.012982:0.007831:0.005879:0.011759:0.012982:0.007831:0.006373:0.012982:0.012982:0.012982:0.006373:0.012982:0.011759:0.005879:0.011759:0.012982:0.011759:0.006373:0.011759:0.009054:0.006373:0.009054:0.005879:0.012982:0.009054:0.006373:0.012982:0.011759:0.005879:0.012982:0.009054:0.006373:0.010301:0.012982:0.005879:0.012982:0.006373:0.012982:0.012982:0.012982:0.005879:0.009054:0.012982:0.012982:0.007831:0.009054:0.005879:0.007831:0.019355:0.015686:0.012982:0.007831:0.006375
emphasizing the need for ongoing research, international collaboration, and:@0.100053:0.851319:0.858272:0.851319:0.858272:0.834703:0.100053:0.834703:0.010301:0.019355:0.012982:0.012982:0.011759:0.009054:0.006373:0.010301:0.006373:0.012982:0.011759:0.005879:0.007831:0.012982:0.010301:0.005879:0.012982:0.010301:0.010301:0.012982:0.005879:0.007831:0.012982:0.009054:0.005879:0.012982:0.012982:0.011759:0.012982:0.006373:0.012982:0.011759:0.005879:0.009054:0.010301:0.009054:0.010301:0.011759:0.009054:0.010301:0.012982:0.006373:0.005879:0.006373:0.012982:0.007831:0.010301:0.009054:0.012982:0.011759:0.007831:0.006373:0.012982:0.012982:0.011759:0.006373:0.005879:0.010301:0.012982:0.006373:0.006373:0.011759:0.012982:0.012982:0.009054:0.011759:0.007831:0.006373:0.012982:0.012982:0.006373:0.005879:0.011759:0.012982:0.012984
regulatory adjustments to address emerging challenges in the field. Following:@0.100053:0.874472:0.870524:0.874472:0.870524:0.857855:0.100053:0.857855:0.009054:0.010301:0.011759:0.012982:0.006373:0.011759:0.007831:0.012982:0.009054:0.011759:0.005879:0.011759:0.012982:0.006373:0.012982:0.009054:0.007831:0.019355:0.010301:0.012982:0.007831:0.009054:0.005879:0.007831:0.012982:0.005879:0.011759:0.012982:0.012982:0.009054:0.010301:0.009054:0.009054:0.005879:0.010301:0.019355:0.010301:0.009054:0.011759:0.006373:0.012982:0.011759:0.005879:0.010301:0.012982:0.011759:0.006373:0.006373:0.010301:0.012982:0.011759:0.010301:0.009054:0.005879:0.006373:0.012982:0.005879:0.007831:0.012982:0.010301:0.005879:0.007831:0.006373:0.010301:0.006373:0.012982:0.006373:0.005879:0.015686:0.012982:0.006373:0.006373:0.012982:0.016909:0.006373:0.012982:0.011761
the lecture, there was an interactive Q&A session where participants had the:@0.100053:0.897624:0.859024:0.897624:0.859024:0.881008:0.100053:0.881008:0.007831:0.012982:0.010301:0.005879:0.006373:0.010301:0.010301:0.007831:0.012982:0.009054:0.010301:0.006373:0.005879:0.007831:0.012982:0.010301:0.009054:0.010301:0.005879:0.016909:0.011759:0.009054:0.005879:0.011759:0.012982:0.005879:0.006373:0.012982:0.007831:0.010301:0.009054:0.011759:0.010301:0.007831:0.006373:0.011759:0.010301:0.005879:0.018132:0.018132:0.018132:0.005879:0.009054:0.010301:0.009054:0.009054:0.006373:0.012982:0.012982:0.005879:0.016909:0.012982:0.010301:0.009054:0.010301:0.005879:0.012982:0.011759:0.009054:0.007831:0.006373:0.010301:0.006373:0.012982:0.011759:0.012982:0.007831:0.009054:0.005879:0.012982:0.011759:0.012982:0.005879:0.007831:0.012982:0.010303
opportunity to ask questions and seek clarifications on the topics discussed.:@0.100053:0.920776:0.854508:0.920776:0.854508:0.904160:0.100053:0.904160:0.012982:0.012982:0.012982:0.012982:0.009054:0.007831:0.012982:0.012982:0.006373:0.007831:0.011759:0.005879:0.007831:0.012982:0.005879:0.011759:0.009054:0.012982:0.005879:0.012982:0.012982:0.010301:0.009054:0.007831:0.006373:0.012982:0.012982:0.009054:0.005879:0.011759:0.012982:0.012982:0.005879:0.009054:0.010301:0.010301:0.012982:0.005879:0.010301:0.006373:0.011759:0.009054:0.006373:0.007831:0.006373:0.010301:0.011759:0.007831:0.006373:0.012982:0.012982:0.009054:0.005879:0.012982:0.012982:0.005879:0.007831:0.012982:0.010301:0.005879:0.007831:0.012982:0.012982:0.006373:0.010301:0.009054:0.005879:0.012982:0.006373:0.009054:0.010301:0.012982:0.009054:0.009054:0.010301:0.012982:0.006375
This session facilitated a deeper understanding of the subject matter.:@0.100053:0.943928:0.782543:0.943928:0.782543:0.927312:0.100053:0.927312:0.015686:0.012982:0.006373:0.009054:0.005879:0.009054:0.010301:0.009054:0.009054:0.006373:0.012982:0.012982:0.005879:0.007831:0.011759:0.010301:0.006373:0.006373:0.006373:0.007831:0.011759:0.007831:0.010301:0.012982:0.005879:0.011759:0.005879:0.012982:0.010301:0.010301:0.012982:0.010301:0.009054:0.005879:0.012982:0.012982:0.012982:0.010301:0.009054:0.009054:0.007831:0.011759:0.012982:0.012982:0.006373:0.012982:0.011759:0.005879:0.012982:0.007831:0.005879:0.007831:0.012982:0.010301:0.005879:0.009054:0.012982:0.012982:0.006373:0.010301:0.010301:0.007831:0.005879:0.019355:0.011759:0.007831:0.007831:0.010301:0.009054:0.006375
REPORT ON :@0.262786:0.093632:0.737718:0.093632:0.737718:0.034273:0.262786:0.034273:0.051928:0.049996:0.046971:0.068902:0.051928:0.047055:0.016805:0.068902:0.055640:0.016806
INTERNATIONAL EXPERT:@0.028277:0.153293:0.972230:0.153293:0.972230:0.093934:0.028277:0.093934:0.023527:0.055625:0.047055:0.049996:0.051928:0.055625:0.054029:0.047055:0.023527:0.068902:0.055625:0.054029:0.046130:0.016805:0.049996:0.048147:0.046971:0.049996:0.051928:0.047057
LECTURE SERIES:@0.174683:0.212955:0.825804:0.212955:0.825804:0.153596:0.174683:0.153596:0.046130:0.049996:0.063104:0.047055:0.057726:0.051928:0.049996:0.016805:0.046466:0.049996:0.051928:0.023527:0.049996:0.046469
16:@0.946343:0.039955:0.975160:0.039955:0.975160:0.018459:0.946343:0.018459:0.013866:0.014951